- Zeroing in on canine atopic dermatitis
- What makes dogs itch?
- Retrospective evaluation of Apoquel® (oclacitinib) for the treatment of atopic dermatitis. Part 2: monitoring for side effects.
- Apoquel vs. Atopica: a comparison of two medications to control atopic dermatitis in dogs
- Retrospective evaluation of Apoquel® (oclacitinib) for the treatment of 117 dogs with atopic dermatitis. Part 1: control of pruritus (itch).
Learn more about RESPIT
Subscribe to the SkinVet e-Newsletter!
Author Archives: skinvet
By Jon Plant, DVM, DACVD There is a huge demand for Apoquel®, the new Zoetis (NYSE: ZTS) drug for dogs with atopic dermatitis or “allergic” dermatitis. I predict that Apoquel sales will exceed $1 billion per year for Zoetis after … Continue reading
By Jon Plant, DVM, DACVD Bad news, good news about Apoquel® from Zoetis (NYSE: ZTS). We learned last week that the Apoquel backorder situation is likely to continue throughout 2014 and into the summer of 2015. That is very sad … Continue reading
By Jon Plant, DVM, DACVD In a somewhat embarrassing setback, yesterday Zoetis (NYSE: ZTS) was forced to inform veterinary customers that Apoquel, their new drug for canine atopic dermatitis, is now on back-order only 3 weeks after its national launch. … Continue reading
By Jon Plant, DVM, DACVD How much do we know about Apoquel’s safety? Quite a lot, I would argue. The short-term safety profile, based on the data collected during multiple randomized-controlled trials at recommended doses looks good. In a 28-day … Continue reading
By Jon Plant, DVM, DACVD Apoquel® (oclacitinib) is the new Zoetis drug for the treatment of atopic and allergic dermatitis in dogs at least 12 months of age. I’ve been prescribing Apoquel for almost 3 months now and I must … Continue reading
Jon D. Plant, DVM, Dipl. ACVD If you haven’t already, you will soon be hearing a lot about APOQUEL® for the management of allergic dermatitis and atopic dermatitis in dogs at least 12 months of age. APOQUEL® is a new … Continue reading
Allergen-specific immunotherapy (ASIT) is frequently used to manage canine atopic dermatitis (AD). The selection of allergens for ASIT is based on intradermal testing (IDT), allergen-specific immunoglobulin E (IgE) assays, patient history, and aerobiological data. In theory, an optimal allergenic extract … Continue reading